Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques

Journal of Nuclear Medicine

Volumn 51, Issue 12, 2010, Pages 1937-1949

  Gotthardt, Martin ^a   Bleeker Rovers, Chantal P ^a   Boerman, Otto C ^a   Oyen, Wim J G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Infectious disease; Inflammation; PET; Radionuclide imaging; SPECT

Indexed keywords

ALBUMIN IN 111; BISPHOSPHONIC ACID DERIVATIVE TC 99M; CHOLINE C 11; FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; IMMUNOGLOBULIN G IN 111; INDIUM 111; LEFLUNOMIDE; MEDRONATE TECHNETIUM TC 99M; METHOTREXATE; NANOCOLL TC 99M; OXIDRONATE TECHNETIUM TC 99M; SALAZOSULFAPYRIDINE; TECHNETIUM 99M; TRACER; TRANSFERRIN GA 67; UNCLASSIFIED DRUG;

ARTERIOGRAPHY; BONE SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; ECHOGRAPHY; ENDOSCOPY; ENTERITIS; GRAFT INFECTION; HUMAN; INFECTION; INFLAMMATORY DISEASE; INTERVERTEBRAL DISK DEGENERATION; METASTATIC INFECTIOUS DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTHESIS INFECTION; PYREXIA IDIOPATHICA; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPONDYLITIS; SYNOVITIS; VASCULITIS;

ARTHRITIS, RHEUMATOID; DIAGNOSTIC IMAGING; FEVER OF UNKNOWN ORIGIN; HUMANS; INFECTION; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; POSITRON-EMISSION TOMOGRAPHY; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; VASCULITIS;

EID: 78651272044     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.076232     Document Type: Review

References (79)

1. 111In-labeled leukocytes - initial experience. Radiology. 2002;223:758-764.
2. Hakim SG, Bruecker CW, Jacobsen H, et al. The value of FDG-PET and bone scintigraphy with SPECT in the primary diagnosis and follow-up of patients with chronic osteomyelitis of the mandible. Int J Oral Maxillofac Surg. 2006;35:809-816.
3. Horger M, Eschmann SM, Pfannenberg C, et al. Added value of SPECT/CT in patients suspected of having bone infection: preliminary results. Arch Orthop Trauma Surg. 2007;127:211-221.
4. van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJ. PET and SPECT in osteomyelitis and prosthetic joint infections: a systematic review. Semin Nucl Med. 2010;40:3-15.
5. Palestro CJ, Love C, Tronco GG, et al. Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection. Radiographics. 2006;26:859-870.
6. Basu S, Zhuang H, Torigian DA, Rosenbaum J, Chen W, Alavi A. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med. 2009;39:124-145.
7. Kälicke T, Schmitz A, Risse JH, et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med. 2000;27:524-528.
8. 111Inlabelled autologous leucocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2002;29:53-60.
9. 18F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med Mol Imaging. 2002;29:516-524.
10. de Winter F, van de Wiele C, Vogelaers D, et al. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am. 2001;83-A:651-660.
11. de Winter F, Gemmel F, van de Wiele C, Poffijn B, Uyttendaele D, Dierckx R. 18-fluorine fluorodeoxyglucose positron emission tomography for the diagnosis of infection in the postoperative spine. Spine (Phila Pa 1976). 2003;28:1314-1319.
12. Palestro CJ, Love C, Miller TT. Imaging of musculoskeletal infection. Best Pract Res Clin Rheumatol. 2006;20:1197-1218.
13. 99mTc-MOAB. J Intern Med. 2008;263:99-106.
14. Nawaz A, Torigian DA, Siegelman ES, Basu S, Chryssikos T, Alavi A. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Mol Imaging Biol. 2009;12:335-342.
15. Hirsch W, Krohmer S, Kluge R, et al. Preliminary results in whole-body MRI in children: a prospective study. Pediatr Radiol. 2005;35:S89.
16. Darge K, Jaramillo D, Siegel MJ. Whole-body MRI in children: current status and future applications. Eur J Radiol. 2008;68:289-298.
17. Van Hoorn R, Vriens D, Postema JP, et al. Evaluation of the of advanced ReSPECT image reconstruction software in a phantom model and in parathyroid scanning [abstract]. Nuklearmedizin. 2010;49:A9.
18. Chang JK, Calligaro KD, Ryan S, Runyan D, Dougherty MJ, Stern JJ. Risk factors associated with infection of lower extremity revascularization: analysis of 365 procedures performed at a teaching hospital. Ann Vasc Surg. 2003;17:91-96.
19. Keidar Z, Nitecki S. FDG-PET for the detection of infected vascular grafts. Q J Nucl Med Mol Imaging. 2009;53:35-50.
20. Fukuchi K, Ishida Y, Higashi M, et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomography findings. J Vasc Surg. 2005;42:919-925.
21. 18F-FDG-PET/CT. J Nucl Med. 2007;48:1230-1236.
22. 18F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging. 2009;36:850-858.
23. 99mTc- hexamethylpropylene amine oxime labelled leukocyte scintigraphy for an aortic graft infection. Interact Cardiovasc Thorac Surg. 2010;10:142-143.
24. 18F-fluorodeoxyglucose PET. Q J Nucl Med Mol Imaging. 2008;52:17-29.
25. 18F-FDG PET/CT for detection of metastatic infection in Gram-positive bacteremia. J Nucl Med. 2010;51:1234-1240.
26. Smolen JS, Aletaha D, Bijlsma JWJ, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631-637.
27. Szkudlarek M, Narvestad E, Klarlund M, et al. Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis, compared with magnetic resonance imaging, conventional radiography and clinical examination. Arthritis Rheum. 2004;50:2103-2112.
28. McQueen FM, Østergaard M. Established rheumatoid arthritis: new imaging modalities. Best Pract Res Clin Rheumatol. 2007;21:841-856.
29. Hoving JL, Buchbinder R, Hall S, et al. A comparison of magnetic resonance imaging, sonography, and radiography of the hand in patients with early rheumatoid arthritis. J Rheumatol. 2004;31:663-675.
30. Ostendorf B, Mattes-György K, Reichelt DC, et al. Early detection of bony alterations in rheumatoid and erosive arthritis of finger joints with high-resolution single photon emission computed tomography, and differentiation between them. Skeletal Radiol. 2010;39:55-61.
31. Roivainen A, Parkkola R, Yli-Kerttula T, et al. Use of positron emission tomography with methyl-11choline and 2-18fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum. 2003;48:3077-3084.
32. Wunder A, Schellenberger E, Mahmood U, et al. Methotrexate induced accumulation of fluorescent annexin V in collagen-induced arthritis. Mol Imaging. 2005;4:1-6.
33. Knockaert DC, Vanneste LJ, Bobbaers HJ. Fever of unknown origin in elderly patients. J Am Geriatr Soc. 1993;41:1187-1192.
34. Chong EW, Robertson AJ. Is temporal artery biopsy a worthwhile procedure? ANZ J Surg. 2005;75:388-391.
35. Blockmans D, Bley T, Schmidt W. Imaging for large vessel vasculitis. Curr Opin Rheumatol. 2009;21:19-28.
36. Schmidt WA, Seifert A, Gromnica-Ihle E, et al. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology. 2008;47:96-101.
37. Schmidt WA, Krause A, Schicke B, Wernicke D. Color Doppler ultrasonography of hand and finger arteries to differentiate primary from secondary forms of Raynaud's phenomenon. J Rheumatol. 2008;35:1591-1598.
38. Blockmans D, De Ceuninck L, Vanderschueren S, et al. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology. 2007;46:672-677.
39. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology. 2008;47:403-408.
40. 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55:131-137.
41. 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med. 2008;49:1107-1113.
42. Bley TA, Uhl M, Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. Am J Neuroradiol. 2007;28:1722-1727.
43. Blockmans D, Coudyzer W, Vanderschueren S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology. 2008;47:1179-1184.
44. Andrews J, Mason JC. Takayasu's arteritis: recent advances in imaging offer promise. Rheumatology. 2007;46:6-15.
45. Schmidt WA, Seipelt E, Krause A, Wernicke D. Carotidynia in Takayasu arteritis. J Rheumatol. 2007;34:231-232.
46. 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging. 2004;31:627-634.
47. Andrews J, Al-Nahhas A, Pennell DJ, et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis. 2004;63:995-1000.
48. Tso E, Flamm SD, White RD, et al. Takayasu's arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum. 2002;46:1634-1642.
49. Gornik HL, Creager MA. Aortitis. Circulation. 2008;117:3039-3051.
50. Meller J, Sahlmann CO, Gürocak O, Liersch T, Meller B. FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis. Q J Nucl Med Mol Imaging. 2009;53:51-63.
51. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS), and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736-755.
52. 18F]-FDG PET and early metabolic response to corticosteroid therapy. Br J Radiol. 2007;80:e67-e71.
53. Teirstein AS, Machac J, Almeida O, et al. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest. 2007;132:1949-1953.
54. Xiu Y, Yu JQ, Cheng E, et al. Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy. Clin Nucl Med. 2005;30:193-195.
55. 67Gacitrate in sarcoidosis imaging. Nuklearmedizin. 2008;47:18-23.
56. Prabhaker HB, Rabinowitz CB, Gibbons FK, O'Donnell FJ, Shepard JA, Aquino SL. Imaging features of sarcoidosis on MDCT, FDG PET, and PET/CT. AJR. 2008;190(suppl):S1-S6.
57. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging. 2008;35:1537-1543.
58. Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut. 2006;55(suppl 1):i1-i15.
59. Spier BJ, Perlman SB, Reichelderfer M. FDG PET in inflammatory bowel disease. Q J Nucl Med Mol Imaging. 2009;53:64-71.
60. Molnár T, Papós M, Gyulai C, et al. Clinical value of technetium-99m-HMPAO-labeled leukocyte scintigraphy and spiral computed tomography in active Crohn's disease. Am J Gastroenterol. 2001;96:1517-1521.
61. Rispo A, Imbriaco M, Celentano L, et al. Noninvasive diagnosis of small bowel Crohn's disease: combined use of bowel sonography and Tc-99m-HMPAO leukocyte scintigraphy. Inflamm Bowel Dis. 2005;11:376-382.
62. Horsthuis K, Bipat S, Bennink RJ, Stooker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy and CT: meta-analysis of prospective studies. Radiology. 2008;247:64-78.
63. 99mTc white blood cells. Radiology. 1999;212:507-513.
64. 99mTc-HMPAO white blood cell scintigraphy. J Nucl Med. 2004;45:1698-1704.
65. Lemberg DA, Issenman RM, Cawdron R, et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:733-738.
66. 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci. 2006;1072:379-385.
67. 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol. 2002;97:1978-1985.
68. Meisner RS, Spier BJ, Einarsson S, et al. Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:993-1000.
69. 18F-FDG PET/CT. J Nucl Med. 2007;48:1053-1059.
70. Das CJ, Makharia G, Kumar R, et al. PET CT enteroclysis: a new technique for evaluation of inflammatory disease of the intestine. Eur J Nucl Med Mol Imaging. 2007;34:2106-2114.
71. Ladas SD, Triantafyllou K, Spada C, et al. European Society of Gastrointestinal Endoscopy (ESGE): recommendations (2009) on clinical use of video capsule endoscopy to investigate small-bowel, esophageal and colonic diseases. Endoscopy. 2010;42:220-227.
72. Banerjee R, Bhargav P, Reddy P, et al. Safety and efficacy of the M2A patency capsule for diagnosis of critical intestinal patency: results of a prospective clinical study. J Gastroenterol Hepatol. 2007;22:2060-2063.
73. Bleeker-Rovers CP, van der Meer JWM, Oyen WJG. Fever of unknown origin. Semin Nucl Med. 2009;39:81-87.
74. 18F]FDG imaging with a double-head coincidence camera and gallium-67 SPECT. Eur J Nucl Med. 2000;27:1617-1625.
75. 111In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004;31:622-626.
76. Buysschaert I, Vanderschueren S, Blockmans D, et al. Contribution of 18fluorodeoxyglucose positron emission tomography to the workup of patients with fever of unknown origin. Eur J Intern Med. 2004;15:151-156. (Pubitemid 38900559)
77. Bleeker-Rovers CP, Vos FJ, Kleijn EM, et al. A prospective multi-center study of fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007;86:26-38.
78. 18F-FDG- PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience. Int J Clin Pract. 2010;64:55-60.
79. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun. 2001;22:779-783.